In-vitro Study [Study Per­for­mance]

posted by M.Vasu – India, 2014-01-29 06:02 (4522 d 00:49 ago) – Posting: # 12286
Views: 3,345

Dear All,

I have a query regarding In-vitro study (Equilibrium binding & Kinetic binding). Equilibrium binding study is considered the pivotal bioequivalence study for FDA submission. As per FDA, drug content of test and reference product cannot differ from that of reference listed product by more than 5 percent. Is this criteria is applicable for in-vitro study? However, analytes to measure (in-vitro study) is unbound bile salts in filtrate.

Thanks
VM

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
139 visitors (0 registered, 139 guests [including 9 identified bots]).
Forum time: 07:51 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5